Final Programme - iuphar

FC01 Clinical pharmacology in the emerging countries
Mon 018 Can steady state plasma concentration of efavirenz predict virologic outcomes in treatment naïve HIV
Ethiopian patients?
Abiy H Eyakem, (Ethiopia), W Amogne, G Yimer, E Makonnen, G Aderaye, A Worku, L Lindquist,
L Bertilsson, J Burhenne, E Aklillu
Mon 019 Population pharmacokinetics of oseltamivir carboxylate in Mexican patients with influenza A(H1N1)
Francisco Flores-Murrieta, (Mexico), M Barranco-Garduño, M Carrasco-Portugal, H León-Molina,
A Cervantes-Nevárez, G Castañeda-Hernández
Mon 020 Analysis of n-acetyltransferase 2 phenotype and genotype in a Tunisian population
E Gaïes, Anis Klouz, (Tunisia), I Salouage, S Trabelsi, I Hamza, N Jebabli, M Aouichri, M Lakhal
Mon 021 Tunisian clinical pharmacology experience
E Gaïes, R Sahnoun, D Bensaid, N Jebabli, I Salouage, S Trabelsi, I Hamza, M Aouichri,
Anis Klouz,(Tunisia), M Lakhal
Mon 022 Estimation of transfer of nifurtimox, for Chagas disease, into breastmilk. Population pharmacokinetics
and simulation analysis
Facundo Garcia-Bournissen, (Canada), J Altcheh, A Panchaud, S Ito
Mon 023 Evaluation of the effect of an extract of Mangifera indica L. in patients with spinocerebellar ataxia
type 2
Mariela Guevara-García, (Cuba), L Velázquez, R Aguilera, R Rodríguez, O Ramírez, D Almaguer,
JC Rodríguez
Mon 024 Cost analysis of antibacterial drugs in a developing country, India
Devi D Gupta, (India), M Gupta
Mon 025 Characterization of resistance to cytosine arabinoside (ARA-C) IN NALM-6 human B leukemia cells
Masaaki Ishikawa, (Japan), S-I Kanno
Mon 026 Potential drug-drug interactions of lopinavir/ritonavir in antiretroviral prescriptions with prescribed daily
doses not according to the recommended antiretroviral doses in South Africa
Norah Lucky Katende-Kyenda, (South Africa), M Lubbe, J Serfontein, I Truter
Mon 027 Complete overhaul of the authorization and single-central ethical committee approval procedure of
clinical trials in Hungary
Peter Kovacs, (Hungary), A Vas
Mon 028 Effect of mastitis on disposition kinetics of levofloxacin following single dose i.v. administration in goats
Birendra Kumar, (India), M Ram, V Singh, R Prasad, K Singh
Mon 029 A phase I clincical study of CKD-732 in combination with capecitabine and oxaliplatin in patients with
metastatic colorectal cancer
Yoon Jung Lee, (South Korea), S Shin, HC Chung, K Park
Mon 030 Latin America a successful emerging market for clinical research
Federico Lerner, (Argentina)
Mon 031 Effect on the expression of CYP450 enzyme in rat liver induced by total panax notoginsenoside and the
potential drug-drug interaction study
Xiao-yu Li, (PR China), G-L Liu, J-C Zhou, G Qian, B Sun, Y-K Guo, J-W Gao
Monday 19 July ■ 13:00 - 14:00 ■ Poster Area 161